Trial Profile
A Retrospective Study to Evaluate the Efficacy and Safety of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis (MSPP)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2018
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2018 New trial record